Identifying Preferred Speech Treatment Approaches among Patients with Parkinson's Disease

Authors

  • Ahmad Abdulaziz Aljafen

    Department of English, College of Education, Majmaah University, Al-Majmaah 15362, Saudi Arabia

DOI:

https://doi.org/10.30564/fls.v7i6.9959
Received: 11 May 2025 | Revised: 20 May 2025 | Accepted: 5 June 2025 | Published Online: 7 June 2025

Abstract

Parkinson's disease (PD) is a debilitating neurological disorder characterized by motor symptoms and significant communication impairments that adversely affect patients' quality of life. Nevertheless, few Parkinson's disease patients seek speech therapy, which may worsen their communication challenges as the disease progresses. Given the limited awareness of Parkinson's disease patient preferences regarding speech approaches, speech therapists face a significant challenge in determining which approaches would be most acceptable to these patients. The aim of this study, therefore, was to identify preferred speech treatment approaches among Saudi patients with Parkinson's disease. A Google Form survey was distributed to PD patients to collect data on their demographics, language difficulties, and treatment preferences, as well as factors influencing these preferences. Findings from 74 Saudi patients with PD indicate a preference for Home Exercise Therapy as a speech treatment approach, due to its convenience in location and scheduling. These results underscore the need to recognize patients' preferred treatment methods to encourage regular participation in speech therapy and potentially mitigate the decline of their communication skills. Future research should explore the long-term effects of allowing PD patients to choose their preferred speech treatment approaches as well as the potential benefits of involving families in the decision-making process.

Keywords:

Parkinson’s Disease; Saudi Patients; Speech Treatment; Home Exercise Therapy

References

[1] Ünal, B., Altuntaş, İ., Erbaş, O., 2020. Parkinson's disease: mechanisms, pathogenesis, animal models and tests. Journal of Experimental and Basic Medical Sciences. 1(3), 135–139. DOI: https://doi.org/10.5606/jebms.2020.75629

[2] Davie, C.A., 2008. A review of Parkinson's disease. British Medical Bulletin. 86(1), 109–127. DOI: https://doi.org/10.1093/bmb/ldn013

[3] Jankovic, J., 2008. Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry. 79(4), 368–376. DOI: https://doi.org/10.1136/jnnp.2007.131045

[4] Tolosa, E., Garrido, A., Scholz, S.W., et al., 2021. Challenges in the diagnosis of Parkinson's disease. The Lancet Neurology. 20(5), 385–397.

[5] Poewe, W., Seppi, K., Tanner, C.M., et al., 2017. Parkinson disease. Nature Reviews Disease Primers, 3(1), 1–21. DOI: https://doi.org/10.1038/nrdp.2017.13

[6] Uwishema, O., Onyeaka, H., Badri, R., et al., 2022. The understanding of Parkinson's disease through genetics and new therapies. Brain and Behavior, 12(5), e2577. DOI: https://doi.org/10.1002/brb3.2577

[7] Holtgraves, T., Fogle, K., Marsh, L., 2013. Pragmatic language production deficits in Parkinson's disease. Advances in Parkinson's Disease. 2(1), 31–36. DOI: https://doi.org/10.4236/apd.2013.21006

[8] Dashtipour, K., Tafreshi, A., Lee, J., et a., 2018. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegenerative Disease Management. 8(5), 337–348. DOI: https://doi.org/10.2217/nmt-2018-0021

[9] Pinto, S., Chan, A., Guimarães, I., et al., 2017. A cross-linguistic perspective to the study of dysarthria in Parkinson's disease. Journal of Phonetics. 64, 156–167. DOI: https://doi.org/10.1016/j.wocn.2017.01.009

[10] Miller, N., 2012. Speech, voice and language in Parkinson's disease: changes and interventions. Neurodegenerative Disease Management. 2(3), 279–289. DOI: https://doi.org/10.2217/nmt.12.15

[11] Pal, A., Pegwal, N., Kaur, S., et al., 2018. Deficit in specific cognitive domains associated with dementia in Parkinson's disease. Journal of Clinical Neuroscience. 57, 116–120. DOI: https://doi.org/10.1016/j.jocn.2018.08.016

[12] Hazan, H., Hilu, D., Manevitz, L., et al., 2012. Early diagnosis of Parkinson's disease via machine learning on speech data. Proceedings of The 2012 IEEE 27th Convention of Electrical and Electronics Engineers in Israel; November 14–17, 2012; Eilat, Israel. pp. 1–4. DOI: https://doi.org/10.1109/EEEI.2012.6377065

[13] Crescentini, C., Mondolo, F., Biasutti, E., et al., 2008. Supervisory and routine processes in noun and verb generation in nondemented patients with Parkinson's disease. Neuropsychologia. 46(2), 434–447. DOI: https://doi.org/10.1016/j.neuropsychologia.2007.08.021

[14] Bertella, L., Albani, G., Greco, E., et al., 2002. Noun verb dissociation in Parkinson's disease. Brain and Cognition. 48(2–3), 277–280.

[15] Boulenger, V., Mechtouff, L., Thobois, S., et al., 2008. Word processing in Parkinson's disease is impaired for action verbs but not for concrete nouns. Neuropsychologia. 46(2), 743–756. DOI: https://doi.org/10.1016/j.neuropsychologia.2007.10.007

[16] Monetta, L., Grindrod, C.M., Pell, M.D., 2009. Irony comprehension and theory of mind deficits in patients with Parkinson's disease. Cortex. 45(8), 972–981. DOI: https://doi.org/10.1016/j.cortex.2009.02.021

[17] Rusz, J., Cmejla, R., Tykalova, T., et al., 2013. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task. The Journal of the Acoustical Society of America. 134(3), 2171–2181. DOI: https://doi.org/10.1121/1.4816541

[18] Novotný, M., Rusz, J., Čmejla, R., et al., 2014. Automatic evaluation of articulatory disorders in Parkinson's disease. IEEE Transactions on Audio, Speech and Language Processing. 22(9), 1366–1378. DOI: https://doi.org/10.1109/TASLP.2014.2329734

[19] Rusz, J., Cmejla, R., Ruzickova, H., et al., 2011. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease. The Journal of the Acoustical Society of America. 129(1), 350–367. DOI: https://doi.org/10.1121/1.3514381

[20] Sapir, S., Ramig, L.O., Fox, C.M., 2011. Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment. Expert Review of Neurotherapeutics. 11(6), 815–830. DOI: https://doi.org/10.1586/ern.11.43

[21] Gustafsson, J.K., Södersten, M., Ternström, S., et al., 2019. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator. Logopedics Phoniatrics Vocology. 44(3), 124–133. DOI: https://doi.org/10.1080/14015439.2018.1435718

[22] Ramig, L.O., Pawlas, A A., Countryman, S., 1995. The Lee Silverman Voice Treatment: A Practical Guide for Treating the Voice and Speech Disorders in Parkinson Disease. National Center for Voice and Speech at the University of Iowa: Johnson County, IA, USA .

[23] Jacob, U.S., Fagbemi, A., Osisanya, A., et al., 2021. Oral motor and articulation therapies on speech intelligibility among persons with Down syndrome. Turkish Journal of Physiotherapy and Rehabilitation. 32(3), 10046–10052.

[24] Morley, M.E., Fox, J., 1969. Disorders of articulation: theory and therapy. British Journal of Disorders of Communication. 4(2), 151–165.

[25] de Camargo Sarpi, T.M.F., Fieri, M., Chamouton, C.S., et al., 2017. Voice and swallowing effects after expiratory muscle strength training program in Parkinson's Disease. Distúrb Comun, São Paulo. 29(2), 274–282. DOI: http://dx.doi.org/10.23925/2176-2724.2017v29i2p274-282

[26] Stemple, J.C., Roy, N., Klaben, B.K., 2018. Clinical Voice Pathology: Theory and Management (Vol. 1). Plural Publishing: San Diego, CA, USA. pp. 1–539.

[27] Behlau, M., Madazio, G., Pacheco, C., et al., 2014. Intensive short-term voice therapy: the Brazilian experience. Perspectives on Voice and Voice Disorders. 24(2), 98–103. DOI: https://doi.org/10.1044/vvd24.2.98

[28] Light, J., 1989. Toward a definition of communicative competence for individuals using augmentative and alternative communication systems. Augmentative and Alternative Communication. 5(2), 137–144. DOI: https://doi.org/10.1080/07434618912331275126

[29] Hill, K., 2010. Advances in augmentative and alternative communication as quality-of-life technology. Physical Medicine and Rehabilitation Clinics. 21(1), 43–58.

[30] Beukelman, D.R., Fager, S., Ball, L., et al., 2007. AAC for adults with acquired neurological conditions: a review. Augmentative and Alternative Communication. 23(3), 230–242. DOI: https://doi.org/10.1080/07434610701553668

[31] Creer, S., Enderby, P., Judge, S., et al., 2016. Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need. International Journal of Language & Communication Disorders. 51(6), 639–653. DOI: https://doi.org/10.1111/1460-6984.12235

[32] Ramig, L.O., Fox, C., Sapir, S., 2008. Speech treatment for Parkinson's disease. Expert Review of Neurotherapeutics. 8(2), 297–309. DOI: https://doi.org/10.1586/14737175.8.2.297

[33] Maas, J.J.L., de Vries, N.M., IntHout, J., et al., 2024. Effectiveness of remotely delivered speech therapy in persons with Parkinson's disease–a randomised controlled trial. EClinicalMedicine. 76, 102823.

[34] Broen, M.P.G., Narayen, N.E., Kuijf, M.L., et al., 2016. Prevalence of anxiety in Parkinson's disease: a systematic review and meta‐analysis. Movement Disorders. 31(8), 1125–1133. DOI: https://doi.org/10.1002/mds.26643

[35] Quelhas, R., Costa, M., 2009. Anxiety, depression, and quality of life in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 21(4), 413–419. DOI: https://doi.org/10.1176/jnp.2009.21.4.413

[36] Dissanayaka, N.N.N.W., White, E., O'Sullivan, J.D., et al., 2014. The clinical spectrum of anxiety in Parkinson's disease. Movement Disorders. 29(8), 967–975. DOI: https://doi.org/10.1002/mds.25937

[37] DiNapoli, E.A., Pierpaoli, C.M., Shah, A., et al., 2017. Effects of home-delivered cognitive behavioral therapy (CBT) for depression on anxiety symptoms among rural, ethnically diverse older adults. Clinical Gerontologist. 40(3), 181–190. DOI: https://doi.org/10.1080/07317115.2017.1288670

[38] Goberman, A., Whitfield, A.J., 2018. Relationships between speech and measures of cognition, fatigue, anxiety, and depression in individuals with Parkinson disease [Master thesis]. Bowling Green, OH, USA: Bowling Green State University. pp. 1–96.

[39] Marxreiter, F., Buttler, U., Gassner, H., et al., 2020. The use of digital technology and media in German Parkinson's disease patients. Journal of Parkinson's Disease. 10(2), 717–27. DOI: https://doi.org/10.3233/JPD-19169

[40] Subramanian, I., Farahnik, J., Mischley, L.K., 2020. Synergy of pandemics: social isolation is associated with worsened Parkinson severity and quality of life. npj Parkinson's Disease. 6(1), 28. DOI: https://doi.org/10.1038/s41531-020-00128-9

[41] Xia, N., Li, H., 2018. Loneliness, social isolation, and cardiovascular health. Antioxidants & Redox Signaling. 28(9), 837–851. DOI: https://doi.org/10.1089/ars.2017.7312

Downloads

How to Cite

Aljafen, A. A. (2025). Identifying Preferred Speech Treatment Approaches among Patients with Parkinson’s Disease. Forum for Linguistic Studies, 7(6), 590–601. https://doi.org/10.30564/fls.v7i6.9959

Issue

Vol. 7 , Iss. 6 (July 2025)

Article Type

Article

License

Copyright © 2025 Ahmad Abdulaziz Aljafen

Creative Commons License

This is an open access article under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) License.